The study aimed to evaluate the effectiveness of prescribing inhaled corticosteroids (ICS) in the emergency department for children with uncontrolled asthma. Given the high prevalence of asthma in children and the significant healthcare costs associated with emergency visits, successful implementation of this intervention could lead to improved patient outcomes and reduced healthcare utilization. However, the trial was terminated due to funding completion, which may limit further exploration of this approach. The market for asthma medications, particularly ICS, remains competitive, with established players dominating. The findings could influence future strategies for asthma management in pediatric populations, but the termination of this trial may hinder immediate commercial opportunities.